Advertisement
Screener

BIOCRYST PHARMACEUTICALS, INC. (BCRX) Auditor

BIOCRYST PHARMACEUTICALS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-26: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Raleigh, North Carolina.
  • 2025-02-25: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Raleigh, North Carolina.
  • 2024-02-27: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Raleigh, NC.
  • 2023-02-27: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Raleigh, North Carolina.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-262025-12-31Ernst & Young LLP42Raleigh, North CarolinaYes
2025-02-252024-12-31Ernst & Young LLP42Raleigh, North CarolinaYes
2024-02-272023-12-31Ernst & Young LLP42Raleigh, NCYes
2023-02-272022-12-31Ernst & Young LLP42Raleigh, North CarolinaYes
2022-02-282021-12-31Ernst & Young LLP42Raleigh, North CarolinaYes
2021-03-012020-12-31Ernst & Young LLPRaleigh, North Carolina
2020-03-132019-12-31Ernst & Young LLPRaleigh, North Carolina
2019-03-142018-12-31Ernst & Young LLPRaleigh, North Carolina
2018-03-122017-12-31Ernst & Young LLPRaleigh, North Carolina
2017-02-272016-12-31Ernst & Young LLPRaleigh, North Carolina
2016-02-262015-12-31Ernst & Young LLPRaleigh, North Carolina
2015-03-022014-12-31Ernst & Young LLPRaleigh, North Carolina
2014-03-102013-12-31Ernst & Young LLP
2013-03-112012-12-31Ernst & Young LLPRaleigh, North Carolina
2012-03-062011-12-31Ernst & Young LLPRaleigh, North Carolina
2011-03-152010-12-31Young LLPBirmingham, Alabama
2010-03-092009-12-31Ernst & Young LLPBirmingham, Alabama
2009-03-062008-12-31Ernst & Young LLPBirmingham, Alabama

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43